News / Korea / yonhap_finance
KOSDAQ Pharma and Biotech Stocks Slide Following Fed's Hawkish Stance
Health Technology · Biotechnology · yonhap_finance · 2026-08-31
000250, 028300, 087010, 141080, 196170, 298380
KOSDAQ-listed pharmaceutical and biotech stocks fell as investors reacted to hawkish comments from Fed official Kevin Warsh regarding potential interest rate hikes.
What Happened
Market Context: Pharmaceutical and biotech stocks on the KOSDAQ index faced downward pressure after Fed official Kevin Warsh’s Jackson Hole speech was interpreted as hawkish. As growth-oriented stocks, these companies are particularly sensitive to interest rate fluctuations, which increase their discount rates.
Stock Performance: Major players in the sector saw significant declines, with Alteogen falling 3.91% and ABL Bio dropping 5.46%. Other notable decliners included Peptron, Ligachem Biosciences, and HLB, reflecting a broad-based retreat in investor sentiment.
Fed Policy Outlook: Warsh emphasized the need for clear evidence of inflation slowing toward target levels, signaling that the Fed remains prepared to raise rates if necessary. The market interpreted this as a warning that a rate hike could be on the table at the next FOMC meeting.
Investor Sentiment: The prospect of a prolonged high-interest-rate environment has led to increased caution among investors. Market participants are now closely watching upcoming economic data and Fed communications for further guidance on monetary policy.